Genetically Engineered Immune Cells Are Showing Promise in Fighting HIV
CAR-T therapy, a treatment that reprograms DNA of immune cells so they attack disease, has been shown to suppress or even eradicate HIV in lab monkeys.
How it works: As Stat explains, the engineered immune cells seek out and bind to the virus and are also themselves immune to HIV infection, allowing them to keep working.
But: The technique, published in PLoS One, was only tested in lab dishes and two animals. It’s also unclear how long the benefits may last. Given that CAR-T therapies have historically been very expensive, it would likely need to be an out-and-out cure to prove successful.
Backstory: We’ve explained how CAR-T shows huge promise in treating cancer, and many firms are already investing heavily in the hope that the technique will find broader application. That hope, this news suggests, may prove to be founded.
Deep Dive
Biotechnology
This nanoparticle could be the key to a universal covid vaccine
Ending the covid pandemic might well require a vaccine that protects against any new strains. Researchers may have found a strategy that will work.
How do strong muscles keep your brain healthy?
There’s a robust molecular language being spoken between your muscles and your brain.
The quest to show that biological sex matters in the immune system
A handful of immunologists are pushing the field to take attributes such as sex chromosomes, sex hormones, and reproductive tissues into account.
This company is about to grow new organs in a person for the first time
A volunteer with severe liver disease will soon undergo a procedure that could lead them to grow a second liver.
Stay connected
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.